Literature DB >> 19308351

The effect of bilio-pancreatic diversion on type 2 diabetes in patients with BMI <35 kg/m2.

C Chiellini1, F Rubino, M Castagneto, G Nanni, G Mingrone.   

Abstract

AIMS/HYPOTHESIS: To aim of the study was to investigate the effect of bilio-pancreatic diversion (BPD) on type 2 diabetes in patients with BMI <35 kg/m(2).
METHODS: OGTTs were performed and anthropometric data were compared between five diabetes patients (BMI 27-33 kg/m(2)) following BPD and seven diabetes patients after a low-energy diet. Insulin secretion was computed by C-peptide deconvolution. A euglycaemic-hyperinsulinaemic clamp was performed only in the BPD group and the M value measured.
RESULTS: One month after BPD, fasting and 2 h post-OGTT glycaemia decreased from 15.22 +/- 3.22 to 6.22 +/- 0.51 mmol/l (p = 0.043), while insulin sensitivity increased significantly. No significant changes were observed in the low-energy diet group. Insulin secretion did not differ significantly after either intervention. Diabetes amelioration (change in HbA(1c) level) was observed up to 18 months after BPD without pharmacological therapy. CONCLUSIONS/
INTERPRETATION: BPD can achieve adequate control of type 2 diabetes also in patients with BMI <35 kg/m(2). The rapid postoperative remission of diabetes is primarily related to an improvement in insulin sensitivity.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19308351     DOI: 10.1007/s00125-009-1333-8

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  10 in total

Review 1.  Follow-up report on the diagnosis of diabetes mellitus.

Authors:  Saul Genuth; K G M M Alberti; Peter Bennett; John Buse; Ralph Defronzo; Richard Kahn; John Kitzmiller; William C Knowler; Harold Lebovitz; Ake Lernmark; David Nathan; Jerry Palmer; Robert Rizza; Christopher Saudek; Jonathan Shaw; Michael Steffes; Michael Stern; Jaako Tuomilehto; Paul Zimmet
Journal:  Diabetes Care       Date:  2003-11       Impact factor: 19.112

2.  Duodenal-jejunal bypass for the treatment of type 2 diabetes in patients with body mass index of 22-34 kg/m2: a report of 2 cases.

Authors:  Ricardo V Cohen; Carlos A Schiavon; José S Pinheiro; Jose Luiz Correa; Francesco Rubino
Journal:  Surg Obes Relat Dis       Date:  2007 Mar-Apr       Impact factor: 4.734

3.  Mechanisms of recovery from type 2 diabetes after malabsorptive bariatric surgery.

Authors:  Caterina Guidone; Melania Manco; Elena Valera-Mora; Amerigo Iaconelli; Donatella Gniuli; Andrea Mari; Giuseppe Nanni; Marco Castagneto; Menotti Calvani; Geltrude Mingrone
Journal:  Diabetes       Date:  2006-07       Impact factor: 9.461

4.  The mechanism of diabetes control after gastrointestinal bypass surgery reveals a role of the proximal small intestine in the pathophysiology of type 2 diabetes.

Authors:  Francesco Rubino; Antonello Forgione; David E Cummings; Michel Vix; Donatella Gnuli; Geltrude Mingrone; Marco Castagneto; Jacques Marescaux
Journal:  Ann Surg       Date:  2006-11       Impact factor: 12.969

5.  Estimation of insulin secretion rates from C-peptide levels. Comparison of individual and standard kinetic parameters for C-peptide clearance.

Authors:  E Van Cauter; F Mestrez; J Sturis; K S Polonsky
Journal:  Diabetes       Date:  1992-03       Impact factor: 9.461

6.  A model-based method for assessing insulin sensitivity from the oral glucose tolerance test.

Authors:  A Mari; G Pacini; E Murphy; B Ludvik; J J Nolan
Journal:  Diabetes Care       Date:  2001-03       Impact factor: 19.112

7.  Bilio-pancreatic bypass for obesity: II. Initial experience in man.

Authors:  N Scopinaro; E Gianetta; D Civalleri; U Bonalumi; V Bachi
Journal:  Br J Surg       Date:  1979-09       Impact factor: 6.939

Review 8.  Bariatric surgery: a systematic review and meta-analysis.

Authors:  Henry Buchwald; Yoav Avidor; Eugene Braunwald; Michael D Jensen; Walter Pories; Kyle Fahrbach; Karen Schoelles
Journal:  JAMA       Date:  2004-10-13       Impact factor: 56.272

9.  Adjustable gastric banding and conventional therapy for type 2 diabetes: a randomized controlled trial.

Authors:  John B Dixon; Paul E O'Brien; Julie Playfair; Leon Chapman; Linda M Schachter; Stewart Skinner; Joseph Proietto; Michael Bailey; Margaret Anderson
Journal:  JAMA       Date:  2008-01-23       Impact factor: 56.272

10.  Effect of laparoscopic mini-gastric bypass for type 2 diabetes mellitus: comparison of BMI>35 and <35 kg/m2.

Authors:  Wei-Jei Lee; Weu Wang; Yi-Chih Lee; Ming-Te Huang; Kong-Han Ser; Jung-Chien Chen
Journal:  J Gastrointest Surg       Date:  2007-10-16       Impact factor: 3.452

  10 in total
  19 in total

1.  Strategies for preventing type 2 diabetes: an update for clinicians.

Authors:  Kaivan Khavandi; Halima Amer; Bashar Ibrahim; Jack Brownrigg
Journal:  Ther Adv Chronic Dis       Date:  2013-09       Impact factor: 5.091

Review 2.  A meta-analysis of short-term outcomes of patients with type 2 diabetes mellitus and BMI ≤ 35 kg/m2 undergoing Roux-en-Y gastric bypass.

Authors:  Wen-Sheng Rao; Cheng-Xiang Shan; Wei Zhang; Dao-Zhen Jiang; Ming Qiu
Journal:  World J Surg       Date:  2015-01       Impact factor: 3.352

Review 3.  Metabolic surgery for the treatment of type 2 diabetes in patients with BMI <35 kg/m2: an integrative review of early studies.

Authors:  M Fried; G Ribaric; J N Buchwald; S Svacina; K Dolezalova; N Scopinaro
Journal:  Obes Surg       Date:  2010-06       Impact factor: 4.129

4.  Comparison of laparoscopic Roux-en-Y gastric bypass with laparoscopic sleeve gastrectomy for morbid obesity or type 2 diabetes mellitus: a meta-analysis of randomized controlled trials.

Authors:  Jian-Fang Li; Dan-Dan Lai; Bin Ni; Kuan-Xue Sun
Journal:  Can J Surg       Date:  2013-12       Impact factor: 2.089

5.  Bariatric surgery in class I obesity : a Position Statement from the International Federation for the Surgery of Obesity and Metabolic Disorders (IFSO).

Authors:  Luca Busetto; John Dixon; Maurizio De Luca; Scott Shikora; Walter Pories; Luigi Angrisani
Journal:  Obes Surg       Date:  2014-04       Impact factor: 4.129

Review 6.  Role of bariatric surgery in diabetes.

Authors:  Paul Poirier; Audrey Auclair
Journal:  Curr Cardiol Rep       Date:  2014-02       Impact factor: 2.931

7.  Time to Glycemic Control - an Observational Study of 3 Different Operations.

Authors:  Alper Celik; Sjaak Pouwels; Fatih Can Karaca; Eylem Çağıltay; Surendra Ugale; İlker Etikan; Deniz Büyükbozkırlı; Yunus Emre Kılıç
Journal:  Obes Surg       Date:  2017-03       Impact factor: 4.129

Review 8.  Role of metabolic surgery in less obese or non-obese subjects with type 2 diabetes: influence over cardiovascular events.

Authors:  Ricardo Cohen; Pedro Paulo Caravatto; Tarissa Petry; David Cummings
Journal:  Curr Atheroscler Rep       Date:  2013-10       Impact factor: 5.113

Review 9.  Effects of bariatric surgery on glucose homeostasis and type 2 diabetes.

Authors:  David Bradley; Faidon Magkos; Samuel Klein
Journal:  Gastroenterology       Date:  2012-08-08       Impact factor: 22.682

Review 10.  Metabolic surgery: the role of the gastrointestinal tract in diabetes mellitus.

Authors:  Francesco Rubino; Sarah L R'bibo; Federica del Genio; Madhu Mazumdar; Timothy E McGraw
Journal:  Nat Rev Endocrinol       Date:  2010-02       Impact factor: 43.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.